Tenet’s 5 Highest-Paid Execs in 2025

Why It Matters

The surge in equity‑based pay ties Tenet’s leadership to long‑term shareholder value, while the financial snapshot shows the company’s growth engine shifting away from traditional hospital margins toward higher‑margin outpatient assets.

Key Takeaways

• CEO Sutaria's pay jumped 75% to $43.1 million, mainly stock.
• Tenet revenue reached $21.3 billion, EBITDA $4.6 billion in 2025.
• Free cash flow more than doubled to $2.53 billion year‑over‑year.
• Net income fell to $1.4 billion after $2.1 billion divestiture gain vanished.
• CFO Sun Park earned $7.37 million, up $2.68 million from cash bonus.

Pulse Analysis

Tenet Healthcare’s compensation strategy mirrors a broader trend among large health systems: rewarding executives with stock that vests over multiple years. By allocating more than $31 million of Sutaria’s $43 million package to equity, the board signals confidence in the company’s long‑term growth trajectory and aligns management incentives with shareholder returns. This approach also cushions cash‑flow pressures, allowing Tenet to reinvest earnings into expanding its ambulatory footprint, a sector that has outperformed traditional inpatient services in recent years.

Financially, Tenet posted a modest revenue increase to $21.3 billion and lifted adjusted EBITDA to $4.6 billion, underscoring the profitability of its specialty‑care and outpatient ventures. Free cash flow more than doubled, providing ample liquidity for further acquisitions or debt reduction. However, net income contracted sharply to $1.4 billion after the one‑time $2.1 billion after‑tax gain from 2024 hospital divestitures evaporated, reminding investors that earnings quality remains tied to strategic asset sales. The company’s aggressive portfolio reshaping—selling 14 hospitals in 2024—has shifted the revenue mix toward higher‑margin services, but also introduces volatility as transition costs materialize.

For investors and industry observers, Tenet’s compensation disclosures raise questions about governance and performance metrics. Equity‑heavy pay packages are justified when tied to measurable outcomes such as cash‑flow generation, return on invested capital, and market share in outpatient care. As the health‑care landscape continues to favor decentralized, specialty‑focused models, executives who can steer successful integration of these assets are likely to command premium remuneration. Stakeholders will watch whether Tenet can sustain its cash‑flow growth and translate it into consistent earnings, thereby validating the lofty compensation levels awarded to its top leaders.